SCHEMBL27619086

SCHEMBL27619086

Cc1ccc(C)n1S(=O)(=O)c1ccc(Nc2ncnc3cc(-c4ncccc4C(F)(F)F)ccc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27600447 0.91 TRPV1 (0.66) TRPV1
SCHEMBL4975516 0.88 TRPV1 (0.75) TRPV1
SCHEMBL4977080 0.87 TRPV1 (0.68) TRPV1
SCHEMBL6755833 0.87 TRPV1 (0.68) TRPV1
SCHEMBL4975461 0.87 TRPV1 (0.72) TRPV1
SCHEMBL4972918 0.86 TRPV1 (0.65) TRPV1
SCHEMBL4973314 0.86 TRPV1 (0.65) TRPV1
SCHEMBL4976247 0.86 TRPV1 (0.75) TRPV1
SCHEMBL4982192 0.86 TRPV1 (0.67) TRPV1
SCHEMBL4973528 0.86 TRPV1 (0.69) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1627944-A Substituted quinazolin-4-ylamine analogues as capsaicin modulators NEUROGEN CORP (US) 2005-06-15 CN claimed